Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,377 | 98 | 98.1% |
| Education | $46.91 | 1 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $603.59 | 23 | $0 (2024) |
| Lundbeck LLC | $363.79 | 16 | $0 (2023) |
| ITI, Inc. | $336.33 | 14 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $306.85 | 7 | $0 (2020) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $176.14 | 12 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $94.50 | 1 | $0 (2022) |
| Supernus Pharmaceuticals, Inc. | $93.31 | 3 | $0 (2024) |
| Indivior Inc. | $87.36 | 4 | $0 (2024) |
| Alkermes, Inc. | $80.89 | 3 | $0 (2024) |
| USWM, LLC | $62.02 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $490.90 | 28 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($176.14) |
| 2023 | $642.83 | 23 | Lundbeck LLC ($219.07) |
| 2022 | $479.20 | 20 | ITI, Inc. ($132.77) |
| 2021 | $212.07 | 9 | ITI, Inc. ($156.54) |
| 2020 | $224.71 | 7 | Sunovion Pharmaceuticals Inc. ($121.35) |
| 2019 | $143.50 | 3 | Sunovion Pharmaceuticals Inc. ($120.30) |
| 2018 | $108.23 | 7 | Sunovion Pharmaceuticals Inc. ($65.20) |
| 2017 | $122.03 | 2 | Otsuka America Pharmaceutical, Inc. ($122.03) |
All Payment Transactions
99 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 11/26/2024 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $27.88 | General |
| Category: CNS | ||||||
| 11/22/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $25.50 | General |
| Category: PSYCHIATRY | ||||||
| 11/15/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $16.88 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/25/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: PSYCHIATRY | ||||||
| 09/27/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $9.93 | General |
| Category: PSYCHIATRY | ||||||
| 09/24/2024 | Orexo US, Inc. | Zubsolv (Drug) | Food and Beverage | Cash or cash equivalent | $14.92 | General |
| Category: Addiction Medicine | ||||||
| 09/07/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: PSYCHIATRY | ||||||
| 08/09/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: PSYCHIATRY | ||||||
| 07/30/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $31.69 | General |
| Category: VIROLOGY | ||||||
| 07/12/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: PSYCHIATRY | ||||||
| 07/10/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: PSYCHIATRY | ||||||
| 07/10/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $3.43 | General |
| Category: PSYCHIATRY | ||||||
| 06/21/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $26.11 | General |
| Category: PSYCHIATRY | ||||||
| 06/14/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: PSYCHIATRY | ||||||
| 05/01/2024 | USWM, LLC | Lucemyra (Drug) | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: Psychiatry/Psychology | ||||||
| 04/26/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: PSYCHIATRY | ||||||
| 04/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $25.32 | General |
| Category: PSYCHIATRY | ||||||
| 04/16/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $26.01 | General |
| Category: OUD | ||||||
| 04/05/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: PSYCHIATRY | ||||||
| 03/23/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: PSYCHIATRY | ||||||
| 03/19/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $22.71 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 03/16/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: PSYCHIATRY | ||||||
| 03/09/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $3.25 | General |
| Category: PSYCHIATRY | ||||||
| 03/08/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $7.84 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 13 | 39 | $9,663 | $3,210 |
| 2022 | 1 | 18 | 45 | $7,415 | $3,671 |
| 2021 | 1 | 13 | 25 | $3,741 | $2,476 |
All Medicare Procedures & Services
3 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 13 | 39 | $9,663 | $3,210 | 33.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 18 | 45 | $7,415 | $3,671 | 49.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 13 | 25 | $3,741 | $2,476 | 66.2% |
About Dr. Renee Harris, MD
Dr. Renee Harris, MD is a Psychiatry healthcare provider based in Bloomfield Hills, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/08/2007. The National Provider Identifier (NPI) number assigned to this provider is 1043350895.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Renee Harris, MD has received a total of $2,423 in payments from pharmaceutical and medical device companies, with $490.90 received in 2024. These payments were reported across 99 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($2,377).
As a Medicare-enrolled provider, Harris has provided services to 44 Medicare beneficiaries, totaling 109 services with total Medicare billing of $9,357. Data is available for 3 years (2021–2023), covering 3 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Bloomfield Hills, MI
- Active Since 02/08/2007
- Last Updated 04/20/2023
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1043350895
Products in Payments
- REXULTI (Drug) $892.08
- CAPLYTA (Drug) $512.47
- LATUDA (Drug) $306.85
- INGREZZA (Drug) $94.50
- SUBLOCADE (Drug) $87.36
- QELBREE (Drug) $74.45
- Lucemyra (Drug) $62.02
- Vivitrol (Drug) $53.01
- ABILIFY MAINTENA (Drug) $43.03
- MAVYRET (Drug) $31.69
- VIVITROL (Drug) $27.88
- TRINTELLIX (Drug) $26.94
- INVEGA SUSTENNA (Drug) $24.21
- JORNAY PM (Drug) $22.71
- Qelbree (Drug) $18.86
- AZSTARYS (Drug) $17.97
- ABILIFY MYCITE (Drug) $17.13
- COBENFY (Drug) $16.88
- BRINTELLIX (Drug) $15.14
- Solyx SIS System (Device) $14.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Bloomfield Hills
Dr. Richard Jackson, M.d, M.D
Psychiatry — Payments: $3.5M
Dr. Jeffrey Kezlarian, Md, MD
Psychiatry — Payments: $15,214
Debora Ferguson, Md, MD
Psychiatry — Payments: $13,493
Dr. A George, Md, MD
Psychiatry — Payments: $6,376
Randy Dean, M.d, M.D
Psychiatry — Payments: $4,023
Toby Hazan, M.d, M.D
Psychiatry — Payments: $2,217